Publication | Closed Access

PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer

Breast OncologyCancer ImmunosurveillancePredicts SurvivalPd-l1 ExpressionMedicineImmunologyTumor ImmunityImmune Checkpoint InhibitorBreast CancerTriple-negative Breast CancerOncologyCell BiologyTumor MicroenvironmentTumor Biology